Potent and highly selective kainate receptor agonist, with an IC50
for inhibition of [3
H]-kainate binding of 35 nM and almost 3,000- and 200-fold selectivity for kainate receptors over AMPA and NMDA receptors respectively. Also selectively inhibits the cloned excitatory amino acid transporter EAAT2 at higher concentrations. Also available as part of the Excitatory Amino Acid Transporter Inhibitor Tocriset™
and Kainate Receptor Tocriset™
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold with the permission of Annovis Inc.
The methylglutamate, SYM 2081, is a potent and highly selective agonist at kainate receptors.
Donevan et al.
Desensitization of kainate receptors by kainate, glutamate and diastereomers of 4-methylglutamate.
Jones et al.
Characterisation of kainate receptor mediated whole-cell currents in rat cultured cerebellar granule cells.
Savidge et al.
(2S,4R)-4-Methylglutamic acid (SYM 2081): a selective, high affinity ligand for kainate receptors.
Zhou et al.
The citations listed below are publications that use Tocris products. Selected citations for SYM 2081 include:
Showing Results 1 - 2 of 2